Daniel DeAngelo, MD PhD

Chief, Division of Leukemia

Dana-Farber Cancer Institute

Daniel J. DeAngelo, MD, PhD is a Professor of Medicine at Harvard Medical School and the Chief of the Division of Leukemia at Dana-Farber Cancer Institute in Boston, Massachusetts.

Dr. DeAngelo’s clinical research focuses on optimizing therapy for adult leukemias, myelodysplastic syndromes and myeloproliferative disorders including systemic mast cell disorders. He is co-chair of the National Cancer Institute (NCI) leukemia steering committee. He serves on the leukemia core committee for the Alliance Cooperative Group and is principal and co-investigator of several ongoing clinical protocols. He also has an interest in the treatment of young adults with leukemia, particularly acute lymphoblastic leukemia and systemic mastocytosis.

Dr. DeAngelo has authored or coauthored more than 200 original peer-reviewed manuscripts, review articles, and book chapters and has presented his work nationally and internationally.

Dr. DeAngelo earned his MD and PhD in molecular genetics from Albert Einstein College of Medicine of Yeshiva University in Bronx, New York. He completed his internship and residency at Massachusetts General Hospital in Boston and clinical fellowships in Medical Oncology and Hematology at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital, both in Boston.